Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1893 1
1895 2
1896 1
1900 1
1907 1
1909 1
1922 2
1925 2
1926 1
1929 2
1934 1
1941 1
1947 1
1999 1
2002 1
2004 2
2005 1
2006 1
2010 1
2011 1
2012 1
2013 2
2014 2
2015 3
2016 3
2017 6
2018 2
2019 3
2020 2
2021 5
2022 7
2023 8
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Copy number signatures and mutational processes in ovarian carcinoma.
Macintyre G, Goranova TE, De Silva D, Ennis D, Piskorz AM, Eldridge M, Sie D, Lewsley LA, Hanif A, Wilson C, Dowson S, Glasspool RM, Lockley M, Brockbank E, Montes A, Walther A, Sundar S, Edmondson R, Hall GD, Clamp A, Gourley C, Hall M, Fotopoulou C, Gabra H, Paul J, Supernat A, Millan D, Hoyle A, Bryson G, Nourse C, Mincarelli L, Sanchez LN, Ylstra B, Jimenez-Linan M, Moore L, Hofmann O, Markowetz F, McNeish IA, Brenton JD. Macintyre G, et al. Among authors: brockbank e. Nat Genet. 2018 Sep;50(9):1262-1270. doi: 10.1038/s41588-018-0179-8. Epub 2018 Aug 13. Nat Genet. 2018. PMID: 30104763 Free PMC article.
Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma.
Böhm S, Faruqi A, Said I, Lockley M, Brockbank E, Jeyarajah A, Fitzpatrick A, Ennis D, Dowe T, Santos JL, Cook LS, Tinker AV, Le ND, Gilks CB, Singh N. Böhm S, et al. Among authors: brockbank e. J Clin Oncol. 2015 Aug 1;33(22):2457-63. doi: 10.1200/JCO.2014.60.5212. Epub 2015 Jun 29. J Clin Oncol. 2015. PMID: 26124480
The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.
Smith P, Bradley T, Gavarró LM, Goranova T, Ennis DP, Mirza HB, De Silva D, Piskorz AM, Sauer CM, Al-Khalidi S, Funingana IG, Reinius MAV, Giannone G, Lewsley LA, Stobo J, McQueen J, Bryson G, Eldridge M; BriTROC Investigators; Macintyre G, Markowetz F, Brenton JD, McNeish IA. Smith P, et al. Nat Commun. 2023 Jul 20;14(1):4387. doi: 10.1038/s41467-023-39867-7. Nat Commun. 2023. PMID: 37474499 Free PMC article.
HISTORY OF MANCHESTER.
Brockbank EM. Brockbank EM. Br Med J. 1929 Jan 26;1(3551):167-71. doi: 10.1136/bmj.1.3551.167. Br Med J. 1929. PMID: 20774431 Free PMC article. No abstract available.
Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian Cancer.
Manchanda R, Sun L, Sobocan M, Rodriguez IV, Wei X, Kalra A, Oxley S, Sideris M, Fierheller CT, Morgan RD, Chandrasekaran D, Rust K, Spiliopoulou P, Miller RE, Crusz SM, Lockley M, Singh N, Faruqi A, Casey L, Brockbank E, Phadnis S, Mills-Baldock T, El-Khouly F, Jenkins LA, Wallace A, Ahmed M, Kumar A, Swisher EM, Gourley C, Norquist BM, Evans DG, Legood R. Manchanda R, et al. Among authors: brockbank e. J Natl Compr Canc Netw. 2024 Apr 18;22(2 D):e237331. doi: 10.6004/jnccn.2023.7331. J Natl Compr Canc Netw. 2024. PMID: 38866043
Surgical treatment of stage IA2 cervical cancer.
Kokka F, Bryant A, Brockbank E, Jeyarajah A. Kokka F, et al. Among authors: brockbank e. Cochrane Database Syst Rev. 2014 May 29;2014(5):CD010870. doi: 10.1002/14651858.CD010870.pub2. Cochrane Database Syst Rev. 2014. PMID: 24874726 Free PMC article. Review.
MINERS' CRAMP.
Brockbank EM. Brockbank EM. Br Med J. 1929 Jan 12;1(3549):65-6. doi: 10.1136/bmj.1.3549.65. Br Med J. 1929. PMID: 20774392 Free PMC article. No abstract available.
Prognosis Following Surgery for Recurrent Ovarian Cancer and Diagnostic Criteria Predictive of Cytoreduction Success: A Systematic Review and Meta-Analysis.
Gaba F, Blyuss O, Chandrasekaran D, Bizzarri N, Refky B, Barton D, Ind T, Nobbenhuis M, Butler J, Heath O, Jeyarajah A, Brockbank E, Lawrence A, Manchanda R, Dilley J, Phadnis S, On Behalf Of The Go Soar Collaborative. Gaba F, et al. Among authors: brockbank e. Diagnostics (Basel). 2023 Nov 20;13(22):3484. doi: 10.3390/diagnostics13223484. Diagnostics (Basel). 2023. PMID: 37998621 Free PMC article. Review.
69 results